The Ethylpropyltryptamine theme is a theme that has captured the interest of many people over time. Since its emergence, Ethylpropyltryptamine has been the subject of debates, discussions and numerous investigations. Its relevance extends to different fields, since it has an impact on society, the economy, technology and many other areas. Ethylpropyltryptamine is a topic that has evolved and adapted to social and cultural changes, always remaining at the forefront of public attention. In this article, we will explore the different aspects of Ethylpropyltryptamine and its importance in today's world.
| Clinical data | |
|---|---|
| Other names | EPT; N-Ethyl-N-propyltryptamine |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug in the tryptamine family. It has been identified in illicit products in Japan.[1]
EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[2]
Analogues of EPT include methylethyltryptamine (MET), methylpropyltryptamine (MPT), diethyltryptamine (DET), dipropyltryptamine (DPT), among others.[2]
It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016.[3]
EPT is unscheduled but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.